VANCOUVER, BC / ACCESS Newswire / October 2, 2025 /BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing in ...

In this interview, Dr. Freya Leech, a researcher at NanoFCM, discusses the current challenges and future prospects in ...

The global pulmonary drug delivery systems market was US$ 53267.55 in 2021. The global pulmonary drug delivery systems market is forecast to reach US$ 91,128.65 million by 2030, growing at a compound ...

While AMT-130 could result in meaningful revenue for ClearPoint, the Huntington's opportunity is relatively modest compared ...

Targeted drug delivery to organs and tissues can significantly increase the effectiveness of their effects and reduce the incidence of adverse reactions. Scientists at Tomsk State University are ...

Berhampur: The silk nano gel injector, a device developed by a team of scientists in Odisha and West Bengal for controlled and targeted drug delivery, was awarded a ...

The synergy of nanoengineering coupled with biotechnology and pharmaceutical development has been well established over the past few decades particularly ...

The new technique, published in Nature Chemistry, could be used to precisely target medicines for cancers or bacterial infections, simultaneously increasing their effectiveness and reducing side ...

Beijing-based biotech unicorn METiS TechBio has rolled out what it calls the world's first AI-powered nano-delivery platform, ...

In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with ...

Lipid nanoparticles (LNPs) have emerged as versatile and widely utilized delivery systems in both academic research and industrial applications, offering immense potential beyond liver-targeted and ...

The global lipid nanoparticles market is projected to reach USD 3.84 billion by 2034, up from USD 1.18 billion in 2025, ...